Lyell Immunopharma, Inc. (LYEL)

14.37USD +0.35% (+0.05)

Over 1M: -2.3%

Style
Area Line Line with markers Steps Candles Hollow candles Bars

Candles and bars need the day’s open, high and low, and need room to be drawn in: past about a year of trading a body is thinner than a hairline, so those three offer the longest window that fits instead.

14 15
7 Aug 12 Aug 17 Aug 20 Aug 25 Aug 28 Aug 2 Sep

Financials Quarterly

Figures
Revenue Gross Profit Operating Income Cost of Revenue Operating Cash Flow Free Cash Flow Net Income

A share count and earnings a share are not here: neither is money, so neither can share this axis. Both have their own panel on All charts.

All charts ›
Q3 '21 — Revenue: 2.8M Q3 '21 — Operating Income: -49.2M Q3 '21 — Operating Cash Flow: -25.5M Q3 '21 — Free Cash Flow: -37.1M Q4 '21 — Revenue: 2.8M Q4 '21 — Operating Income: -47.5M Q4 '21 — Operating Cash Flow: -33.2M Q4 '21 — Free Cash Flow: -43.5M Q1 '22 — Revenue: 553K Q1 '22 — Operating Income: -68.6M Q1 '22 — Operating Cash Flow: -47.9M Q1 '22 — Free Cash Flow: -57.6M Q2 '22 — Revenue: 35.7M Q2 '22 — Operating Income: -37.3M Q2 '22 — Operating Cash Flow: -44.3M Q2 '22 — Free Cash Flow: -51.5M Q3 '22 — Revenue: 3K Q3 '22 — Operating Income: -66.4M Q3 '22 — Operating Cash Flow: -37.1M Q3 '22 — Free Cash Flow: -39.9M Q4 '22 — Revenue: 48.4M Q4 '22 — Operating Income: -14.8M Q4 '22 — Operating Cash Flow: -40.3M Q4 '22 — Free Cash Flow: -44.8M Q1 '23 — Revenue: 65K Q1 '23 — Operating Income: -62.6M Q1 '23 — Operating Cash Flow: -46.2M Q1 '23 — Free Cash Flow: -47.7M Q2 '23 — Revenue: 27K Q2 '23 — Operating Income: -65.9M Q2 '23 — Operating Cash Flow: -39.2M Q2 '23 — Free Cash Flow: -40.1M Q3 '23 — Revenue: 25K Q3 '23 — Operating Income: -59M Q3 '23 — Operating Cash Flow: -37.7M Q3 '23 — Free Cash Flow: -37.9M Q4 '23 — Revenue: 13K Q4 '23 — Operating Income: -59.5M Q4 '23 — Operating Cash Flow: -40.6M Q4 '23 — Free Cash Flow: -40.7M Q1 '24 — Revenue: 3K Q1 '24 — Operating Income: -55.6M Q1 '24 — Operating Cash Flow: -42M Q1 '24 — Free Cash Flow: -42M Q2 '24 — Revenue: 13K Q2 '24 — Operating Income: -51.5M Q2 '24 — Operating Cash Flow: -38.1M Q2 '24 — Free Cash Flow: -38.4M Q3 '24 — Revenue: 34K Q3 '24 — Operating Income: -50.5M Q3 '24 — Operating Cash Flow: -35M Q3 '24 — Free Cash Flow: -35.1M Q4 '24 — Revenue: 11K Q4 '24 — Operating Income: -201.1M Q4 '24 — Operating Cash Flow: -47.2M Q4 '24 — Free Cash Flow: -47.3M Q1 '25 — Revenue: 7K Q1 '25 — Operating Income: -57.4M Q1 '25 — Operating Cash Flow: -54.7M Q1 '25 — Free Cash Flow: -55M Q2 '25 — Revenue: 8K Q2 '25 — Operating Income: -47.1M Q2 '25 — Operating Cash Flow: -34.5M Q2 '25 — Free Cash Flow: -34.6M Q3 '25 — Revenue: 15K Q3 '25 — Operating Income: -37.3M Q3 '25 — Operating Cash Flow: -28.6M Q3 '25 — Free Cash Flow: -28.6M Q4 '25 — Revenue: 6K Q4 '25 — Operating Income: -127.6M Q4 '25 — Operating Cash Flow: -32.3M Q4 '25 — Free Cash Flow: -32.6M Q1 '26 — Revenue: 2K Q1 '26 — Operating Income: -44.3M Q1 '26 — Operating Cash Flow: -38.5M Q1 '26 — Free Cash Flow: -38.6M Q2 '26 — Revenue: 4K Q2 '26 — Operating Income: -47.3M Q2 '26 — Operating Cash Flow: -33.9M Q2 '26 — Free Cash Flow: -34.2M -200M -150M -100M -50M 0 50M
Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26
Revenue Operating Income Operating Cash Flow Free Cash Flow

How it scores

For a valuation multiple, the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

0.5
ROIC -682.0%
Accruals -37.0%
Asset turnover 8.7e-05×
ROA -79.9%
ROCE -94.5%
ROE -106.3%
Capex / sales —
EBITDA margin —
FCF margin —
Gross margin —
OCF / EBIT —
OCF margin —
OE margin —
Oper. margin —
Profit margin —
SBC / sales —

1 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

0.8
EV/Sales 5482.8×
EV/OE -0.85×
P/C 1.7×
P/B 1.5×
FCF yield -38.0%
Div. yield —
EV/EBIT —
EV/GP —
Fwd P/E —
P/E —
PEG —

2 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

1.0
RPO / sales —
RPO growth —
Segment HHI —

2 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

7.2
ND/EBITDA 1.4
Cash runway 1.5 yr
Debt / Eq 0.0×
Debt payback 0.0 yr
Quick ratio 5.4×
F-score 1.3 pts
Cash / Debt —
Interest cover —
Payout —

3 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

2.6
Sales CAGR 4Y -75.9%
Sales/sh Y/Y -65.6%
Sales Q/Q -50.0%
Shares change +30.8%
Div. growth —
EBIT CAGR —
EBIT Y/Y —
EPS CAGR 4Y —
EPS Y/Y —
EPS next Y —

4 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.